TotalMarketCap

Nurix Therapeutics

NRIXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.625 B

$14.88 -6.72%

Close of 6 Nov 2026

As of 6 Nov 2026, Nurix Therapeutics (NRIX) has a market capitalization of $1.63B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$84.0M

#2546 by revenue

Earnings

-$264.5M

Loss-making

Shares outstanding

109,249,814

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #104Agios PharmaceuticalsAGIO$1.70B
  2. #105Generate BiomedicinesGENB$1.64B
  3. #106Nurix TherapeuticsNRIX$1.63B
  4. #107Ani PharmaceuticalsANIP$1.60B
  5. #108SELLAS Life Sciences GroupSLS$1.59B

What if Nurix Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$258,461.53

Per share 17,372× higher

Bitcoin $1.53T

$13,984.90

Per share 940× higher

Apple $5.02T

$45,911.13

Per share 3,086× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Nurix Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.